-
1
Prospectives of T-cells genetic programming in adoptive immunotherapy of malignancies
Published 2016-09-01Subjects: Get full text
Article -
2
Regional and intratumoral adoptive T-cell therapy
Published 2024-12-01“…Building upon the experience of regional administration in other immunotherapies, the regional administration of adoptive cell therapies is being assessed to overcome this challenge, granting a first round of access of the transferred T cells to the tumor niche and thereby ensuring their activation and expansion. …”
Get full text
Article -
3
ADOPTIVE CELL THERAPY: CURRENT ADVANCES
Published 2020-03-01“…The main part of the article provides information on the mechanisms of adoptive T cell (unmodified and genetically modified) transfer, the creation of dendritic cell vaccines and cytokine-induced killers (CIK). …”
Get full text
Article -
4
Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients
Published 2025-02-01“…Therapeutic strategies include adoptive transfer, cytokine modulation, and optimized delivery. …”
Get full text
Article -
5
Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy
Published 2024-01-01“…These models shall serve an indepth study of how to overcome barriers that limit antitumor activity of adoptively transferred T cells.…”
Get full text
Article -
6
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
Published 2016-05-01Get full text
Article -
7
Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy
Published 2025-07-01“…Adoptive transfer of Tregs for the treatment of autoimmune disorders such as arthritis and allergic airway inflammation, graft-versus-host disease (GvHD) and rejection following transplant have shown promise in early phase clinical trials. …”
Get full text
Article -
8
Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling.
Published 2014-01-01“…<h4>Conclusion</h4>Treg numbers are increased whereas their function is compromised in mice with that underwent experimental infarction. Transfer of exogeneous Tregs results in attenuation of myocardial remodeling whereas their ablation has no effect. …”
Get full text
Article -
9
Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis
Published 2017-01-01“…Following adoptive transfer of iTregs and iTregmtDC to mice with CIA, the clinical and histopathologic scores, serum levels of IFN-γ, TNF-α, IL-17, IL-6, IL-10, TGF-β and anti-CII antibodies, and the distribution of the CD4+ Th subset were assessed. …”
Get full text
Article -
10
-
11
-
12
CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
Published 2025-01-01Get full text
Article -
13
Adoptive transfer of membrane-restricted IL-12-TCR T cells promotes antigen spreading and elimination of antigen-negative tumor variants
Published 2024-11-01“…The tumor-bearing mice then underwent 5.5 Gy total body irradiation, followed by adoptive transfer of OT-I TCR-T cells engineered with or without caIL-12.Results TCR-T cells (OT-I) delivered caIL-12 to the B16-U-OVA tumor sites and induced robust tumor control and survival benefits in mice bearing a heterogeneous tumor with OVA-negative variants. caIL-12 exerted its effect on OVA-negative B16 variants primarily by priming and activating endogenous antitumor CD8 T cells via antigen spreading. …”
Get full text
Article -
14
An integral membrane constitutively active heparanase enhances the tumor infiltration capability of NK cells
Published 2025-12-01Subjects: “…Adoptive cell transfer…”
Get full text
Article -
15
Regenerative and hepatospecific activity of total RNA from xenogenic bone marrow cells
Published 2021-04-01Subjects: Get full text
Article -
16
-
17
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Published 2024-06-01“…Background How distinct methods of host preconditioning impact the efficacy of adoptively transferred antitumor T helper cells is unknown.Methods CD4+ T cells with a transgenic T-cell receptor that recognize tyrosinase-related peptide (TRP)-1 melanoma antigen were polarized to the T helper 17 (Th17) phenotype and then transferred into melanoma-bearing mice preconditioned with either total body irradiation or chemotherapy.Results We found that preconditioning mice with a non-myeloablative dose of total body irradiation (TBI of 5 Gy) was more effective than using an equivalently dosed non-myeloablative chemotherapy (cyclophosphamide (CTX) of 200 mg/kg) at augmenting therapeutic activity of antitumor TRP-1 Th17 cells. …”
Get full text
Article -
18
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
Published 2024-11-01Subjects: Get full text
Article -
19
Adoptive cell therapy with tumor-infiltrating lymphocytes in combination with nivolumab in patients with advanced melanoma
Published 2024-12-01“…Results: Between 2020 and 2022, we enrolled 11 patients and 9 underwent a TIL transfer (median transfused cell number: 66.25 × 109). …”
Get full text
Article -
20
NECTIN-4-redirected T cell Antigen Coupler T cells bearing CD28 show superior antitumor responses against solid tumors
Published 2024-12-01Subjects: Get full text
Article